Wholly-Owned Subsidiary Halucenex Life Sciences Inc. Achieves Remission In 80% Of First Five Patients In Phase II Clinical Trial Cannabis Investing News
Goodness Growth Holdings and Grown Rogue International Announce the Completed Issuance of Warrants Psychedelics Investing
Melodiol Global Health: Global Portfolio of Strategic Cannabis and Plant-based Businesses Company News
COMPASS Pathways Is Accelerating Patient Access To Evidence-Based Innovation In Mental Health Care Psychedelics Investing
Seelos Therapeutics Announces Encouraging Data from an In Vivo Study of SLS-005 in an Aggressive Preclinical Model of Alzheimer's Disease Psychedelics Investing
How COMPASS Pathways Is Leveraging AI To Revolutionize The Mental Healthcare Space Psychedelics Investing
Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide Psychedelics Investing
One Year Into Kabir Nath’s Leadership, Compass Pathways’ Phase 3 Trial For Innovative Treatment Resistant Depression Progressing Psychedelics Investing
